InnoCare Pharma Ltd. A - Asset Resilience Ratio

Latest as of June 2025: 3.04%

InnoCare Pharma Ltd. A (688428) has an Asset Resilience Ratio of 3.04% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥284.24 Million

Cash + Short-term Investments

Total Assets

CN¥9.36 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2024)

This chart shows how InnoCare Pharma Ltd. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down InnoCare Pharma Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥284.24 Million	3.04%
Total Liquid Assets	CN¥284.24 Million	3.04%

Asset Resilience Insights

Limited Liquidity: InnoCare Pharma Ltd. A maintains only 3.04% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

InnoCare Pharma Ltd. A Industry Peers by Asset Resilience Ratio

Compare InnoCare Pharma Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Zelluna ASA OL:ZLNA	Biotechnology	75.65%
Shenzhen CAU Technology Co Ltd SHE:000004	Biotechnology	6.20%
Pacific Shuanglin Bio pharmacy Co Ltd SHE:000403	Biotechnology	6.88%
Jiangsu Sihuan Bioengineering Co Ltd SHE:000518	Biotechnology	0.03%
Nanhua Bio Medicine Co Ltd SHE:000504	Biotechnology	11.93%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%
Hualan Biological EngineeringInc SHE:002007	Biotechnology	14.68%
Da An Gene Co Ltd of Sun Yat-Sen University SHE:002030	Biotechnology	4.35%

Annual Asset Resilience Ratio for InnoCare Pharma Ltd. A (2021–2024)

The table below shows the annual Asset Resilience Ratio data for InnoCare Pharma Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	11.30%	CN¥1.06 Billion	CN¥9.41 Billion	+8.26pp
2022-12-31	3.04%	CN¥313.29 Million	CN¥10.32 Billion	-1.25pp
2021-12-31	4.29%	CN¥317.06 Million	CN¥7.40 Billion	--

pp = percentage points

About InnoCare Pharma Ltd. A

SHG:688428 China Biotechnology

Market Cap

$1.21 Billion

CN¥8.27 Billion CNY

Market Cap Rank

#8594 Global

#2074 in China

Share Price

CN¥30.80

Change (1 day)

-1.60%

52-Week Range

CN¥19.50 - CN¥33.51

All Time High

CN¥33.51